Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01860187
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
C24 | 3-({2-[(4-CARBAMIMIDOYL-PHENYLAMINO)- METHYL]-3-METHYL-3H-BENZOIMIDAZOLE- 5-CARBONYL}-PYRIDIN-2-YL-AMINO)- PROPIONIC ACID ETHYL ESTER | B,C | 1KTS | 0.74 |  |
312 | 2-(5-{5-[AMINO(IMINIO)METHYL]-1H- BENZIMIDAZOL-2-YL}-2'-METHOXY-6- OXIDO-1,1'-BIPHENYL-3-YL)SUCCINATE | A | 1O2Z | 0.72 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B,C,D,E,F | 1KQO | 0.74 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 2H29 | 0.74 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1NUQ | 0.74 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A | 1WXG | 0.74 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B,C,D,E,F | 1KAQ | 0.74 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1EE1 | 0.74 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B,C,D | 3E27 | 0.74 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A | 1XQD | 0.74 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 2H2A | 0.74 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1IFX | 0.74 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1XNG | 0.74 | |
HT1 | 2'-(4-ETHOXYPHENYL)-5-(4-METHYL- 1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE | A,B | 403D | 0.71 | |
| HT1 | 2'-(4-ETHOXYPHENYL)-5-(4-METHYL- 1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE | A | 129D | 0.71 | |
| HT1 | 2'-(4-ETHOXYPHENYL)-5-(4-METHYL- 1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE | A,B | 130D | 0.71 | |
| HT1 | 2'-(4-ETHOXYPHENYL)-5-(4-METHYL- 1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE | A | 3F8C | 0.71 | |
A45 | 3-(5-AMINO-7-HYDROXY-[1,2,3]TRIAZOLO[4,5- D]PYRIMIDIN-2-YL)-BENZOIC ACID | A | 1RRI | 0.71 | |
T87 | [(1-{2[(4-CARBAMIMIDOYL-PHENYLAMINO)- METHYL]-1-METHYL-1H-BENZOIMIDAZOL- 5-YL}-CYCLOPROPYL)-PYRIDIN-2-YL- METHYLENEAMINOOXY]-ACETIC ACID ETHYL ESTER | B,C | 1G30 | 0.71 | |
| T87 | [(1-{2[(4-CARBAMIMIDOYL-PHENYLAMINO)- METHYL]-1-METHYL-1H-BENZOIMIDAZOL- 5-YL}-CYCLOPROPYL)-PYRIDIN-2-YL- METHYLENEAMINOOXY]-ACETIC ACID ETHYL ESTER | A | 1G2L | 0.71 | |
| T87 | [(1-{2[(4-CARBAMIMIDOYL-PHENYLAMINO)- METHYL]-1-METHYL-1H-BENZOIMIDAZOL- 5-YL}-CYCLOPROPYL)-PYRIDIN-2-YL- METHYLENEAMINOOXY]-ACETIC ACID ETHYL ESTER | A | 1OYQ | 0.71 | |
DVP | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN- 6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE- 4-CARBOXYLATE | A,B,C,D,E,F, G,H | 3H4V | 0.7 | |
656 | 2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL- 2-YL}-6-ISOBUTOXYBENZENOLATE | A | 1O2K | 0.7 | |
| 656 | 2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL- 2-YL}-6-ISOBUTOXYBENZENOLATE | A | 1O2J | 0.7 | |
7CS | (3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT- 3-YL 1H-PYRROLO[2,3-B]PYRIDINE- 3-CARBOXYLATE | A | 2QHM | 0.74 | |
AGN | A | 1GNP | 0.71 | | |
FE1 | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN- 6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE- 4-CARBOXYLATE | A,B,C,D | 2QHX | 0.71 | |
E89 | 6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]- 1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN- 8-ONE | A,D | 1Y5X | 0.7 | |
DOT | 3'ANTHRANILOYL-2'-DEOXY-ADENOSINE- 5'-TRIPHOSPHATE | A,B,C,D,E,F | 1LVC | 0.79 | |
G98 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(1S)-3-amino- 1-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B,E,I,L,P | 3E8E | 0.7 | |
| G98 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(1S)-3-amino- 1-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B | 3E8D | 0.7 | |
090 | N-(2,3-DIHYDRO-7,8-DIMETHOXYIMIDAZO[1,2- C] QUINAZOLIN-5-YL)NICOTINAMIDE | A | 2CHX | 0.7 | |
3GO | 4-[[(2R,3S,4R,5R)-5-[6-amino-8- (quinolin-6-ylmethylamino)purin- 9-yl]-3,4-dihydroxy-oxolan-2-yl]methoxymethyl]benzonitrile | A | 3FZM | 0.74 | |
IQA | (5-OXO-5,6-DIHYDRO-INDOLO[1,2-A]QUINAZOLIN- 7-YL)-ACETIC ACID | A | 1OM1 | 0.72 | |
655 | 2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL- 2-YL}-6-(CYCLOPENTYLOXY)BENZENOLATE | B | 1O3P | 0.71 | |
| 655 | 2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL- 2-YL}-6-(CYCLOPENTYLOXY)BENZENOLATE | A | 1O2I | 0.71 | |
NXX | A,B,C,D | 3DLA | 0.74 | | |
| NXX | A,B,C | 2QTR | 0.74 | | |
NBD | N6-BENZYL-NICOTINAMIDE-ADENINE- DINUCLEOTIDE | A,B,C,D | 1GYQ | 0.71 | |
607 | 2-(2'-AMINO-5-{5-[AMINO(IMINIO)METHYL]- 1H-BENZIMIDAZOL-2-YL}-6-OXIDO-1,1'- BIPHENYL-3-YL)SUCCINATE | A | 1O36 | 0.71 | |
AAI | trans-4-(7-carbamoyl-1H-benzimidazol- 2-yl)-1-propylpiperidinium | A | 2RCW | 0.71 | |
BZC | A | 1EFY | 0.73 | | |
2IG | 6-ETHYL-5-[9-(3-METHOXYPROPYL)- 9H-CARBAZOL-2-YL]PYRIMIDINE-2,4- DIAMINE | A,B | 2G1O | 0.7 | |
A3D | 3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE | A,B,C,D | 1PZG | 0.71 | |
| A3D | 3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE | A | 1DRV | 0.71 | |
| A3D | 3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE | A,B | 2EWD | 0.71 | |
| A3D | 3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE | A,B,C,D | 1PZF | 0.71 | |
XAE | 3-(2-DEOXY-5-O-PHOSPHONO-BETA-D- ERYTHRO-PENTOFURANOSYL)-3H-IMIDAZO[4,5- G]QUINAZOLIN-8-AMINE | A,B | 2ICZ | 0.7 | |
ONA | A,C | 2GVZ | 0.77 | | |
AM9 | 6-(2,6-dimethylphenyl)-2-{[4-(4- methylpiperazin-1-yl)phenyl]amino}pyrimido[5',4':5,6]pyrimido[1,2- a]benzimidazol-5(6H)-one | A | 3BYO | 0.71 | |
MNT | 2'(3')-O-N-METHYLANTHRANILOYL-ADENOSINE- 5'-DIPHOSPHATE | A | 1LVK | 0.79 | |